Hansa Biopharma AB (publ) (STO:HNSA)
45.14
-2.18 (-4.61%)
Nov 20, 2026, 5:29 PM CET
Hansa Biopharma AB Employees
Hansa Biopharma AB had 131 employees as of June 30, 2026. The number of employees decreased by 9 or 6.43% compared to the same quarter last year. That makes Hansa Biopharma AB the 29,743rd largest employer in the world and 342nd in Sweden.
Employees
131
Change (1Y)
-9
Growth (1Y)
-6.43%
Revenue / Employee
2.72M SEK
Profits / Employee
-7.25M SEK
Market Cap
4.59B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 131 | -9 | -6.43% |
| Mar 31, 2026 | 122 | -16 | -11.59% |
| Dec 31, 2025 | 125 | -10 | -7.41% |
| Sep 30, 2025 | 133 | -2 | -1.48% |
| Jun 30, 2025 | 140 | -6 | -4.11% |
| Mar 31, 2025 | 138 | -28 | -16.87% |
| Dec 31, 2024 | 135 | -33 | -19.64% |
| Sep 30, 2024 | 135 | -33 | -19.64% |
| Jun 30, 2024 | 146 | -16 | -9.88% |
| Mar 31, 2024 | 166 | 7 | 4.40% |
| Dec 31, 2023 | 168 | 18 | 12.00% |
| Sep 30, 2023 | 168 | 23 | 15.86% |
| Jun 30, 2023 | 162 | 17 | 11.72% |
| Mar 31, 2023 | 159 | 18 | 12.77% |
| Dec 31, 2022 | 150 | 19 | 14.50% |
| Sep 30, 2022 | 145 | 18 | 14.17% |
| Jun 30, 2022 | 145 | 32 | 28.32% |
| Mar 31, 2022 | 141 | 40 | 39.60% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioArctic AB | 150 |
| Oncopeptides AB | 71 |
| Egetis Therapeutics AB | 61 |
| Vicore Pharma Holding AB | 50 |
| Saniona AB | 44 |
| Genovis AB (publ.) | 43 |
| AlzeCure Pharma AB | 10 |
| Flerie AB | 8 |
Hansa Biopharma AB News
- 5 days ago - Hansa Biopharma AB Transcript: Jefferies Global Healthcare Conference - Transcripts
- 10 days ago - Hansa's Q3 Loss Widens To SEK 17 Mln As Idefirix Market Expands To Australia - Nasdaq
- 11 days ago - Hansa Biopharma AB Earnings Call Transcript: Q3 2026 - Transcripts
- 11 days ago - Hansa Biopharma AB Quarterly report: Q3 2026 - Filings
- 11 days ago - Hansa Biopharma AB Slides: Q3 2026 - Filings
- 11 days ago - Hansa Biopharma Reports Third Quarter and Interim Year to Date 2026 Financial Results - PRNewsWire
- 19 days ago - Hansa Biopharma AB Slides: Corporate presentation - Filings
- 4 weeks ago - Hansa Biopharma announces positive Idefirix PAES results presented in the High-Impact Clinical Trials session at ASN Kidney Week - PRNewsWire